Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
2,1200
Trial Sponsor
Clinical Trial Start Date
2000
0Primary Completion Date
2005
0Study Completion Date
2005
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Drug0
Interventional Trial Phase
Phase 40
Official Name
A Randomized, Comparator Controlled, Double-Blind Study of the Liver Safety of Pioglitazone HCl vs Glyburide With Metformin and Insulin as Part of Step Therapy in Subjects With Type 2 (Non-Insulin Dependent) Diabetes0
Last Updated
February 28, 2012
0Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
Quadruple0
Masked Party
Care Provider0
Outcomes Assessor0
Participant0
Investigator0
Other attributes
Intervention Treatment
Pioglitazone0
Glyburide0
Study summary
The purpose of this study is to determine the liver safety of pioglitazone, once daily (QD), versus glyburide taken with metformin and insulin.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
